- Report
- March 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,697GBP
- Report
- March 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
Canada
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
China
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
Germany
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
India
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
Canada
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
China
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 150 Pages
India
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 173 Pages
Canada
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 182 Pages
China
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 174 Pages
Germany
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 175 Pages
India
From €4281EUR$4,850USD£3,697GBP
- Report
- February 2026
- 178 Pages
Japan
From €4281EUR$4,850USD£3,697GBP
- Report
- January 2026
- 150 Pages
Japan
From €4281EUR$4,850USD£3,697GBP
- Report
- January 2026
- 150 Pages
India
From €4281EUR$4,850USD£3,697GBP
- Report
- December 2025
- 150 Pages
Germany
From €4281EUR$4,850USD£3,697GBP
- Report
- December 2025
- 150 Pages
Germany
From €4281EUR$4,850USD£3,697GBP
- Report
- December 2025
- 150 Pages
Germany
From €4281EUR$4,850USD£3,697GBP
- Report
- December 2025
- 150 Pages
Germany
From €4281EUR$4,850USD£3,697GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more